| Revolution Medicines, Inc. |
Director |
Common Stock |
2,338,884 |
$93,087,583 |
$39.80 |
26 Jun 2025 |
Direct |
| Magenta Therapeutics, Inc. |
Director |
Common Stock |
4,100 |
$49,200 |
$12.00 |
26 Aug 2021 |
Direct |
| Tango Therapeutics, Inc. |
Director |
Common Stock |
17,500 |
$19,950 |
$1.14 |
05 Jun 2025 |
Direct |
| Blueprint Medicines Corp |
Director |
Common Stock |
0 |
$0 |
$101.84 |
17 Jul 2025 |
Direct |
| Relay Therapeutics, Inc. |
Director |
Stock Option (Right to Buy) |
136,681 |
|
|
06 Jun 2025 |
Direct |
| Tango Therapeutics, Inc. |
Director |
Stock Option (Right to Buy) |
37,500 |
|
|
05 Jun 2025 |
Direct |
| OPKO HEALTH, INC. |
Director |
Stock Option (Right to Buy) |
30,000 |
|
|
22 Jun 2023 |
Direct |
| Magenta Therapeutics, Inc. |
Director |
Stock Option (Right to Buy) |
18,188 |
|
|
01 Jun 2021 |
Direct |
| Revolution Medicines, Inc. |
Director |
Stock Option (Right to Buy) |
11,574 |
|
|
26 Jun 2025 |
Direct |
| Blueprint Medicines Corp |
Director |
Stock Option (Right to Buy) |
0 |
|
|
17 Jul 2025 |
Direct |
| EQRx, Inc. |
Executive Chairman, Director |
Common Stock |
0 |
|
$2.21 |
09 Nov 2023 |
Direct |
| EQRx, Inc. |
Executive Chairman, Director |
Earn-out Shares |
0 |
|
|
09 Nov 2023 |
Direct |
| EQRx, Inc. |
Executive Chairman, Director |
Stock Option (Right to Buy) |
0 |
|
|
09 Nov 2023 |
Direct |